EUVIMEDEUVIMED entdecken
Crossref

Abstract 13403: Oxidized Phospholipid-Enriched Lipoproteins Are Associated with Greater Symptom Burden in Refractory Angina

Aleksi Leikas, Juha Hartikainen, Jens Kastrup, Anthony Mathur, Mariann Gyongyosi, Abbas Qayyum, Matthew Kelham, Kevin Hamzaraj, Seppo Yla-Herttuala, Sotirios Tsimikas

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.13403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Aleksi Leikas und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oxidized phospholipids (OxPL) are potent proinflammatory mediators implicated in endothelial dysfunction, vascular inflammation, and plaque progression. Lipoprotein(a) [Lp(a)], the major plasma carrier of OxPL, may mediate part of its atherothrombotic risk through associated OxPL burden. Refractory angina (RA) remains a major unmet clinical challenge, and prior studies showing improved angina and myocardial perfusion with Lp(a) and OxPL apheresis suggest that OxPL-related pathways contribute to RA. However, the relationship between circulating OxPL levels and symptom severity in RA remains undefined. Research Questions: We investigated whether OxPL carried on apolipoprotein B-100 and apolipoprotein(a) [OxPL-apoB and OxPL-apo(a)] are associated with angina severity in RA patients.

Methods

In this hypothesis-generating, cross-sectional analysis, 89 Finnish, Danish, Austrian, and English patients with RA were analyzed from the Kuopio Angiogenesis Trial 301 and the ReGenHeart datasets. OxPL-apoB, OxPL-apo(a), and Lp(a) were measured at baseline, and concurrent symptom assessment was performed using the Canadian Cardiovascular Society (CCS) classification. Multivariable analyses adjusted for age, sex, PCSK9 inhibitor use, and dataset were performed to assess associations of OxPL and Lp(a) with CCS class ≥3 angina.

Results

Demographics, comorbidities, and medication use were generally similar across biomarker strata. Elevated OxPL-apoB (>10 nmol/L) and OxPL-apo(a) (>30 nmol/L), representing the >80 th percentile in the CASABLANCA study in patients undergoing clinically-indicated coronary angiography, were present in 45.2% (28/62) and 51.6% (32/62), respectively, and elevated Lp(a) (>125 nmol/L) was present in 22.5% (20/89) of patients. The highest quartile of OxPL-apoB and Lp(a) was associated with greater odds of CCS class ≥3 angina (OR 7.13; 95% CI 1.49-34.10; P=0.014 and OR 9.00; 95% CI 1.87-43.26; P=0.006, respectively). Each 1-SD increase in OxPL-apoB and Lp(a) was associated with greater odds of CCS class ≥3 angina (OR 1.69; 95% CI 0.96-2.98; P=0.070 and OR 2.17; 95% CI 1.12-4.20; P=0.021). The highest quartile and each 1-SD increase in OxPL-apo(a) were associated with a non-significantly higher odds of CCS class ≥3 angina (OR 2.24; 95% CI 0.70-7.17; P=0.173 and OR 1.46; 95% CI 0.89-2.38; P=0.134, respectively).

Conclusion

Circulating OxPL-rich lipoproteins are highly prevalent in RA and may identify patients with worse angina. The substantially greater prevalence of elevated OxPL biomarkers relative to elevated Lp(a) suggests that enhanced oxidative modification may amplify Lp(a)-associated risk in patients with RA. These findings support further investigation of OxPL-enriched lipoproteins as potential markers of symptomatic ischemic burden in RA.

Zitieren

APA

Leikas, A., Hartikainen, J., Kastrup, J., Mathur, A., Gyongyosi, M., Qayyum, A., Kelham, M., Hamzaraj, K., Yla-Herttuala, S., & Tsimikas, S. (2026). Abstract 13403: Oxidized Phospholipid-Enriched Lipoproteins Are Associated with Greater Symptom Burden in Refractory Angina. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.13403

Vancouver

Leikas A, Hartikainen J, Kastrup J, Mathur A, Gyongyosi M, Qayyum A, et al. Abstract 13403: Oxidized Phospholipid-Enriched Lipoproteins Are Associated with Greater Symptom Burden in Refractory Angina. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.13403

BibTeX
@article{Leikas2026,
  author = {Leikas, Aleksi and Hartikainen, Juha and Kastrup, Jens and Mathur, Anthony and Gyongyosi, Mariann and Qayyum, Abbas and Kelham, Matthew and Hamzaraj, Kevin and Yla-Herttuala, Seppo and Tsimikas, Sotirios},
  title = {Abstract 13403: Oxidized Phospholipid-Enriched Lipoproteins Are Associated with Greater Symptom Burden in Refractory Angina},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.13403}
}
Kostenlos starten →